Helius Medical Technologies, Inc. (NASDAQ:HSDT) headquartered in Newtown, will host a conference call for the investment community to discuss the 2Q20 financial results on 12th August 2020 at 5:00 PM Eastern Time.
The conference call will also be webcast live under the investor relations section of the website heliusmedical.com
Earnings Expectation
Helius Medical Technologies, Inc. is reporting second quarter financial results on Wednesday 12th August 2020, after market close.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 2.00 million ~ $ 2.00 million
Click Here For More Historical Outlooks Of Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The companys product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function.
